Mode
Text Size
Log in / Sign up
N/A N=1,901 Randomized Treatment

Messages About Reduced Nicotine in Combusted Tobacco Products

Health Communication · Smoking · Smoking, Tobacco · Smoking Behaviors · Risk Behavior

Enrolled (actual)
1,901
Serious AEs
Results posted
Aug 2024
Primary outcome: Primary: Perceived Health Risk of VLNCs (Absolute) — 4.09; 3.81; 4.03; 3.87 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Reduced nicotine message exposure (Behavioral); Modified risk message exposure (Behavioral); Combined message exposure (reduced nicotine + modified risk) (Behavioral); Control message exposure (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Georgia State University
Primary completion
Feb 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Perceived Health Risk of VLNCs (Absolute)
4.09; 3.81; 4.03; 3.87
SECONDARY
Interest in Trying Reduced Nicotine Cigarettes
3.09; 2.95; 3.08; 3.15
SECONDARY
Intention to Switch From Cigarettes to Electronic Nicotine Products
3.15; 2.97; 2.91; 2.86
SECONDARY
Perceived Addictiveness of VLNCs
3.68; 3.74; 3.65; 3.71
SECONDARY
VLNC Comparative Risk Perceptions
2.97; 2.81; 2.89; 2.78
SECONDARY
VLNC Policy Support
3.20; 3.08; 3.21; 3.14
SECONDARY
Perceived Message Effectiveness
4.55; 3.98; 4.32; 2.33
SECONDARY
Perceived Health Risk of VLNCs (Absolute) at Post-test
3.68; 3.62; 3.68; 3.62
SECONDARY
Smoking Behavior
11.64; 11.97; 12.78; 11.97

Summary

The investigators will conduct a message-exposure experiment with nationally representative samples of smokers, dual-users (cigarettes and e-cigarettes), and young adult non-smokers (aged 18-29). Experimental messages will address the reduction of nicotine in cigarettes. Participants will also complete a follow-up survey after 2 weeks, measuring their recall of the messages and behaviors since message exposure.

Eligibility Criteria

Inclusion Criteria

  • Being 18 years old or older:
  • Belonging to one of three groups of participants; 900 current exclusive smokers, 450 dual users (cigarettes and e-cigarettes), and 450 young adult (18-29) non-smokers, evenly split between men and women.
  • Enrolled in existing nationally representative panel where recruitment is based

Exclusion Criteria

  • None.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05506046). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search